Search - tctmd.com

Displaying 121 - 140 of 542

Sort: Relevancy | Date

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Conference News AHA 2023

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Caitlin E. Cox

November 07, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

L.A. McKeown

September 20, 2023

News Daily News

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

Todd Neale

September 19, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

Advertisement

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FDA Grants Tirzepatide a New Indication for Obesity Management

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

November 2023 News Roundup

October 2023 News Roundup

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

September 2023 News Roundup

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Statin Therapy Still Lacking for Many US Patients With ASCVD

August 2023 News Roundup

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content